Local Navigation

• Florida Medicaid Home Page
• Abuse & Overpayment
• Area Offices
• Assistive Care Services
• Behavioral Health
• Child Health Services
• Cost Reimbursement
• Disease Management
• Draft Handbook Review
• Durable Medical Equipment (DME)
• Family Planning
• HCBS Waivers
• HIPAA
• Intergovernmental Transfer (IGT) Workgroup
• Long-Term Care Partnership
• Medicaid Encounter Data System (MEDS)
• Medicaid HMOs
• Medicaid Privacy Notice
• Medicaid Procurements
• Medicaid Reform
• Medicaid Research Contracts and Evaluations
• Medicaid State Plan
• MediKids
• MediPass
• Newborn Eligibility
• Nursing Facility Provider Information
• Nursing Home Transition
• Organ Transplant Advisory Council
• Payment Error Rate Measurement (PERM)
• Pharmacy Services
• Preferred Drug List
• Provider Service Network (PSN)
• Provider Training e-Library
• Quality in Managed Care
• Recent Presentations
• Reimbursement Workgroups Meetings
• Report Medicaid Fraud
• Statewide Medicaid Managed Care Program
• Substance Abuse Services
• Utilization Review

Medicaid Pharmaceutical & Therapeutics Committee

The purpose of the Medicaid Pharmaceutical & Therapeutics Committee is to develop and implement a voluntary Medicaid preferred prescribed drug designation program, as mandated in the 2000 session of the Florida legislature, SB 2034.

Committee Members 11/1/2011

Florida Statute 409.91195 requires the appointment of committee members by the Governor.

Schedule of Meetings

Please follow this link to see information regarding the next scheduled meetings for the Pharmaceutical and Therapeutics Committee, the Drug Utilization Review Board, and the Prescribing Pattern Review Panel.

Florida Medicaid Preferred Drug List.

The Florida Medicaid Preferred Drug List (PDL) is a listing of prescription products selected by the Pharmaceutical & Therapeutics Committee as cost effective choices for clinician consideration when prescribing for Medicaid recipients. The PDL will be used to inform clinicians of effective products that provide favorable net costs to Medicaid. The PDL educates clinicians about cost effective choices in prescribing for Medicaid recipients, but clinicians always retain the option of selecting the drug product they feel is most appropriate for their patient by calling the Therapeutic Consultation Program at (877) 553-7481. If the prescriber cannot readily obtain authorization the pharmacist may dispense a 72 hour supply. The pharmacist may also use their professional judgement if other situations arise that would necessitate a 72 hour emergency supply.